Petronella B. Ottevanger
Papers
1
Total Citations
36
H-Index
1
About
Dr. Petronella B. Ottevanger is a leading oncologist whose research centers on gynecological cancers, with a particular focus on fertility-preserving treatments and neoadjuvant chemotherapy strategies. Her most cited work, a 2020 study on neoadjuvant chemotherapy followed by vaginal radical trachelectomy for FIGO 2018 stage 1B2 cervical cancer (36 citations), represents a significant contribution to the field. This research directly addresses a critical clinical challenge: offering women with tumors between 2 and 4 cm an alternative to radical hysterectomy, thereby preserving fertility without compromising oncological outcomes. By evaluating both oncological safety and fertility results, Dr. Ottevanger’s work provides evidence that can change standard treatment paradigms for young patients facing cervical cancer. Her research bridges the gap between aggressive cancer control and quality of life, demonstrating that effective treatment need not come at the cost of reproductive potential. Through this landmark study and her ongoing investigations, Dr. Ottevanger continues to shape clinical guidelines and offer hope to patients seeking to preserve their fertility while fighting cancer.
Research Focus
Key Achievements
Top Papers
- 1